Genomics & Omics Analysis - software & AI news

Daily news on software, AI, and companies shaping genomics & omics analysis.

Showing 121 results
Press release cover image

Aug 13, 2026

FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test

Investigational AI-powered multiomic test is being developed for adults ages 50-80 at high risk who are not currently participating in guideline-recommended lung cancer screeningBRISBANE, Calif., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Freenome, Inc. (Nasdaq: FRNM), an early cancer detection company developing blood-based screening tests, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to SimpleScreen™ Lung, the company’s investigational lu
Press release cover image

Aug 11, 2026

Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination

Nature Communications study finds UNCOVERseq™ delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methodsFindings provide a more rigorous framework for prioritizing potential off-target sites for confirmation and safety assessment in CRISPR-based therapeutic development, supporting more confident progress from promising science toward responsible therapeutic impactStudy defines sequencing, replication and process-control conditions relevant to
Press release cover image

Aug 11, 2026

GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy

New offering integrates virtual clinicians to create a scalable channel to increase availability of GeneDx exome testing for eligible children facing specialty-care barriersGAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced the launch of a new online offering designed to expand accessibility of exome testing across the U.S. at scale for pediatric patients with global developmental
A base editing tool on a lab bench with scientific instruments in a laboratory setting.

Aug 10, 2026

BaseMap ABE Launched for Off-Target Characterization in Base Editing Therapeutic Development

Broken String Biosciences has introduced BaseMap ABE, a novel tool designed to enhance the characterization of off-target effects in adenine base editing (ABE) applications.This launch comes as base editing is increasingly recognized for its ability to facilitate precise genomic alterations. As ABE technologies gain traction in therapeutic settings, there is a growing need for reliable methods to identify and characterize unintended off-target modifications. According to Terry Pizzie, the CEO of
Press release cover image

Aug 6, 2026

Caris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer

Findings published in Cancer Research Communications highlight potential to inform extended endocrine therapy decisionsIRVING, Texas, Aug. 6, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading TechBio company, today announced the publication of a study in Cancer Research Communications demonstrating the ability of a multimodal, multitask deep learning model to estimate late distant recurrence risk in hormone receptor-positive (HR+) early breast cancer.The study, titled "Development and
Press release cover image

Aug 6, 2026

Shape Therapeutics and Rett Syndrome Research Trust Announce Partnership to Advance a One-Time AI-Designed RNA Editing Therapy for Rett Syndrome

Collaboration will evaluate Shape's intravenously delivered RNAfix® gene therapy designed to correct the MECP2 R168X mutation in non-human primates (NHP) SEATTLE, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA editing-based gene therapy, today announced a partnership with the Rett Syndrome Research Trust (RSRT) to advance SHP-401, an investigational one-time gene therapy for Rett syndrome. Under the agreement, RSRT will fund translational studies to evaluate Shape’s RNAf
Press release cover image

Aug 5, 2026

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry and an accompanying software update for its Vega systems. Together, the updates expand the range of HiFi applications laboratories can run in-house and allow customers to match sequencing performance and run time to specific project needs. Vega SPRQ-Nx brings the same core chemistry used on th
Press release cover image

Aug 5, 2026

Revolune Announces Service Provider Program with CellCarta, Concept Life Sciences, and Propath UK

OBERKOCHEN, Germany, Aug. 4, 2026 /PRNewswire/ -- Revolune today announced the launch of its Service Provider Program, a new partner model designed to expand customer access to Revolune-powered multiplex immunofluorescence (mIF) workflows through experienced service laboratories. The program launches with CellCarta, Concept Life Sciences, and Propath UK as participating service providers, giving researchers and translational teams multiple routes to evaluate, adopt, and scale flexible multiplex
A petri dish with RNA sequences in a dimly lit lab setting.

Aug 4, 2026

Chinese life sciences AI model GeneLLM emerges as the 'Biological DeepSeek'

China's Jindu Life Science has introduced GeneLLM, a pioneering multi-omics large model, aiming to redefine AI's role in life sciences, akin to DeepSeek.GeneLLM stands out as the first model pre-trained on raw omics data, marking a significant advancement in the field. Developed by a team of scholars from Oxford, this model is designed to interpret complex biological information using RNA sequences as its foundational tokens. By leveraging vast amounts of unprocessed sequencing data, GeneLLM aim
Genomic sequencing machine in a laboratory

Jul 29, 2026

Precision oncology move to put Amaravati on India's genomics map

Andhra Pradesh is making strides in precision oncology with the establishment of an Integrated Genomics Solutions Center in Amaravati, a collaboration between the state government and AstraZeneca India. This initiative marks a significant advancement in cancer care, aiming to integrate genomics and artificial intelligence for personalized treatment.The Memorandum of Understanding (MoU) was signed in the presence of Chief Minister N Chandrababu Naidu, emphasizing the project's focus on lung and b
Probiotic capsule and gut microbiome illustration

Jul 28, 2026

From Queensland to Silicon Valley: Australian student founders join startup elite with AI driven biotech venture

Two Australian university students, Anis Mihrshahi and Leon Mojarrabi, have joined the prestigious Y Combinator startup accelerator with their biotech venture, GutGutGoose. This achievement highlights a growing trend of student-led innovation in the life sciences sector, particularly in the realm of personalized healthcare.GutGutGoose aims to revolutionize the probiotic market by leveraging artificial intelligence to develop customized probiotics tailored to individual gut microbiomes. The found
A minimalist representation of DNA and a laboratory flask on a dark background.

Jul 28, 2026

A.P. inks pact with AstraZeneca to set up Genomic Solutions Centre in Amaravati

Andhra Pradesh has officially partnered with AstraZeneca India to create an Integrated Genomic Solutions Centre in Amaravati, a significant advancement in precision cancer care. This initiative aims to establish India's first comprehensive research and treatment ecosystem focused on precision oncology, utilizing cutting-edge genomic technologies for personalized cancer diagnosis and treatment.The Memorandum of Understanding (MoU) was signed in the presence of Chief Minister N. Chandrababu Naidu,